Primplantation Genetic Screening (PGS) for aneuploidy using Next Generation Sequencing (NGS) is currently the most effective method for optimize selection embryos for transfer.

The test allows determining whether a given individual is exposed to the higher risk of developing breast and/or ovarian cancer, connected with carrying the specific mutations in BRCA genes.

Identification of the cause of miscarriage may help in planning an optimal course of treatment for couples who experienced pregnancy loss.

Personalized Genetic Screening Test is a set of tests allowing comprehensive selection of genetic diagnostics personalized for each Patient.